A systemic lupus erythematosus (SLE) disease expert emphasizes benefits of hydroxychloroquine, burst of steroid treatments
Search results for: FLARE
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
What Adult Rheumatologists Need to Know about Juvenile Arthritis
How to recognize distinctions between pediatric and adult arthritis
Rheuminations: Circadian Rhythms May Play Role in Inflammatory Disease
Research into how the timing of light and dark exposures control our lives could provide clues to why some people have immunologic disorders
ACR Winter Rheumatology Symposium: Tips for ANCA Testing
How to select the correct testing method and interpret conflicting results from antineutrophil cytoplasmic antibody tests
Is Predisone 3 mg/day an Appropriate Dose for Patients with Rheumatoid Arthritis?
Long-term, low-dose prednisone at less than 5 mg/day appears tolerable and effective for many patients with rheumatoid arthritis (RA)
ACR/ARHP Annual Meeting 2012: Risk of Immunosuppression from Rheumatic Disease Therapies Poses Challenge for Rheumatologists
Therapies can raise patients’ risk of contracting tuberculosis or other infectious diseases, complicating treatment
Rheumatology Drug Updates
Information on new approvals and medication safety that rheumatologists need to know
Two Inflammatory Conditions—Polymyalgia Rheumatica and Giant Cell Arteritis—Share Clinical Connection
Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) have common clinical and epidemiologic links, but they need not occur synchronously
ACR/ARHP Annual Meeting 2012: New Research Delves Into the Risk of Comorbidities for Patients with Lupus
Studying factors that may lead to life-threatening comorbidities such as lymphoma and thrombosis could give rheumatologists clearer direction on treating patients with SLE
- « Previous Page
- 1
- …
- 55
- 56
- 57
- 58
- 59
- …
- 65
- Next Page »